Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-22 Purchase | 2019-11-26 10:00 am | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 94,500 | $1.2166 | $114,968 | 94,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-15 Option Award | 2023-12-15 9:46 pm | N/A 2033-12-15 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2022-12-20 Option Award | 2022-12-22 11:22 am | N/A 2032-12-20 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 625,000 | $0 | 625,000 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-15 9:25 pm | N/A 2031-12-13 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 6:30 pm | N/A 2030-12-31 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 5:30 pm | N/A 2030-06-16 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:05 pm | N/A 2030-01-01 | Matinas BioPharma Holdings Inc. | MTNB | Kucinski Keith A Chief Financial Officer | 350,000 | $0 | 350,000 (Direct) | View |